Comment
Author: Admin | 2025-04-28
Solid organ transplantation the induction of immunosuppression in the early phase is required to2 Prevent graft rejection Improve graft and patient survival Improve overall patient quality of life >90% graft survival one-year post transplantation with immunosuppressantWith the immunosuppressive drugs, one-year graft survival now exceeds 90% in most centres3We at Viatris support needy patients to get the Tacrolimus and Everolimus level testing to maintain healthy graft and intern improve QOL. References: Wood KJ, Goto R. Mechanisms of rejection: Current perspectives [Internet]. Transplantation. U.S. National Library of Medicine; [cited 2022Apr20]. Available from: https://pubmed.ncbi.nlm.nih.gov/22138818/ Hartono C, Muthukumar T, Suthanthiran M. Immunosuppressive drug therapy. Cold Spring Harbor Perspectives in Medicine. 2013;3(9). Afzali B, Lechler R, Lombardi G. Graft rejection: Immunological suppression. Encyclopedia of Life Sciences. 2010. Product Portfolio Viatris and ImmunosuppressantsViatris offers a wide range of immunosuppressant for the prevention of organ transplant in patients who have had a renal or liver transplant. Graftix Division Introduction Immunosuppressant (IS) Introduction:Viatris Transplant Care business redefines the healthcare landscape by planting hope and life in millions of patientsGraft rejection is the major barrier to successful transplantation1. Viatris in collaboration with strategic partners and sales and marketing efforts helps patients to access quality medicines on time and at an affordable rate.2The Viatris India transplant care division strives to empower individuals to live life minus the fear of graft failure by optimizing immunosuppressant balance. Our dedicated patient support program adds an edge to the care that we extend.Our immunosuppressant range of products: Mylimus® (Tacrolimus) Lanolimus® (Everolimus) Graftide M® (Mycophenolate mofetil) Graftide S® (Mycophenolate sodium) References: Wood KJ, Goto R. Mechanisms of rejection: current perspectives. Transplantation. 2012 Jan 15;93(1):1-10. Viatris: Global Healthcare Company. Available at: https://www.viatris.com/en. Accessed on: 22 February 2022.
Add Comment